BD-200

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameBD-200
Drug Alias NameBD-200BD200BD 200
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-NECTIN4Anti-Trop-2DNA topoisomerase I inhibitors
TargetsNectin-4Tumor-associated calcium signal transducer 2DNA topoisomerase I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiolojic Design Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiolojic Design Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A